Women who develop high blood pressure in their 40s may be more likely to develop dementia later in life, according to a study published today, 4 October 2017, in the medical journal Neurology.
Researchers in New Mexico and Croatia have tested a non-invasive brain scanning technique known as magnetoencephalography, or MEG, as an early biomarker of Alzheimer's disease.
Axovant Sciences today announced that the Phase 3 MINDSET trial of its Alzheimer’s drug intepirdine has failed to bring meaningful improvements in cognition or daily functioning.